CESC schedules AGM

Mumbai, Aug. 18 -- CESC announced that the Annual General Meeting(AGM) of the company will be held on 11 September 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

How much of Malaysia must we destroy before we call it heritage? - Khoo Ying Hooi

Kuala Lampur, Aug. 18 -- I teach politics, and I have never believed that politics can be understood without history. Institutions, identities and the way we see ourselves as a country all come from s... Read More

Gulshan Polyols AGM scheduled

Mumbai, Aug. 18 -- Gulshan Polyols announced that the Annual General Meeting(AGM) of the company will be held on 11 September 2026. Published by HT Digital Content Services with permission from Capit... Read More

Max Alert Systems to convene AGM

Mumbai, Aug. 18 -- Max Alert Systems announced that the Annual General Meeting(AGM) of the company will be held on 10 September 2026. Published by HT Digital Content Services with permission from Cap... Read More

milky mist ipo : మిల్కీ మిస్ట్ ఐపీఓ ఇన్వెస్టర్లకు 18శాతం లిస్టింగ్ గెయిన్స్..

భారతదేశం, ఆగస్టు 18 -- భారత స్టాక్ మార్కెట్లో మిల్కీ మిస్ట్ ఫుడ్ డైరీ షేర్లు మంగళవారం (ఆగస్టు 18, 2026) మంచి లాభాలతో అరంగేట్రం చేశాయి. మార్కెట్ అంచనాలను తలకిందులు చేస్తూ ఈ షేర్లు అదరగొట్టాయి. మిల్కీ మ... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More

• ««
• «
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• »
• »»